A Study of Olezarsen (ISIS 678354) in Participants With Hypertriglyceridemia and Atherosclerotic Cardiovascular Disease, or With Severe Hypertriglyceridemia

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1478 participants.

Also called NCT05610280

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 1,478 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT05610280
  • EudraCT 2022-501486-53
Other papers using this trial's data
  • Effect of APOC3 Inhibition With Olezarsen on Coronary Atherosclerosis: Essence-TIMI 73b Imaging Study Circulation, 2026-05-19 DOI, PubMed 41910513
  • Targeting APOC3 with Olezarsen in Moderate Hypertriglyceridemia The New England journal of medicine, 2025-10-02 DOI, PubMed 40888739

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
United States, Bulgaria, Canada, Czechia, Denmark, France, Hungary, Italy, Netherlands, Norway, Poland, Portugal, Slovakia, Spain (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT05610280. Randomized; quadruple masking; primary purpose treatment. Start 2022-11-21 (actual); primary completion 2024-08-08 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Study of Olezarsen (ISIS 678354) in Participants With Hypertriglyceridemia and Atherosclerotic Cardiovascular Disease, or With Severe Hypertriglyceridemia
Condition
Hypertriglyceridemia
Condition
Cardiovascular Diseases
Condition
Atherosclerosis
Intervention (Drug)
Olezarsen
Intervention (Drug)
Placebo
Lead sponsor
Ionis Pharmaceuticals, Inc. (class: industry)

Record details

Record id
cardio:ct-nct05610280
Content hash
5cfeb6a725fc083e98cb0b4502386efcb84fe30ee3a2918521e0138588ed082c